Production (Stage)
Kits Eyecare Ltd.
KTYCF
$9.96
$0.363.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.85% | 37.61% | 32.19% | 23.75% | 26.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.85% | 37.61% | 32.19% | 23.75% | 26.12% |
| Cost of Revenue | 17.31% | 34.86% | 34.88% | 24.13% | 27.75% |
| Gross Profit | 43.89% | 42.73% | 27.02% | 22.96% | 22.81% |
| SG&A Expenses | 21.49% | 27.49% | 22.42% | 19.52% | 18.23% |
| Depreciation & Amortization | -59.03% | -56.48% | -61.28% | -56.69% | -14.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.50% | 30.88% | 29.22% | 21.33% | 23.73% |
| Operating Income | 675.03% | 3,916.62% | 1,652.20% | 140.01% | 51.90% |
| Income Before Tax | 2,543.91% | 617.07% | -54.39% | 126.67% | 106.36% |
| Income Tax Expenses | 3,560.45% | 560.69% | 69.27% | 176.41% | 106.61% |
| Earnings from Continuing Operations | 2,251.37% | 640.98% | -72.95% | 115.51% | 106.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,251.37% | 640.98% | -72.95% | 115.51% | 106.30% |
| EBIT | 675.03% | 3,916.62% | 1,652.20% | 140.01% | 51.90% |
| EBITDA | 2,072.40% | 485.41% | 100.93% | 149.52% | 160.66% |
| EPS Basic | 2,240.00% | 637.39% | -72.81% | 115.30% | 106.25% |
| Normalized Basic EPS | 2,525.00% | 615.69% | -54.88% | 126.51% | 106.28% |
| EPS Diluted | 2,385.71% | 487.07% | -61.33% | 114.43% | 105.83% |
| Normalized Diluted EPS | 2,600.00% | 580.39% | -54.55% | 124.65% | 105.76% |
| Average Basic Shares Outstanding | 1.30% | 0.50% | 0.53% | 0.25% | 0.27% |
| Average Diluted Shares Outstanding | 0.89% | 7.80% | 1.95% | 7.19% | 6.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |